The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

In this Healio Video Perspective from Retina 2025, Ramiro Ribeiro, MD, PhD, of EyePoint Pharmaceuticals, discusses Duravyu, a vorolanib intravitreal insert. According to Ribeiro, in the DAVIO 2 trial, ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as ... Read More The ...

Equality Health, a trailblazing value-based care (VBC) enabler with a Medicaid-first care model, continues to lead the charge in advancing health equity and improving outcomes for underserved ...

Align ENT + Allergy is thrilled to partner with Greco MD and Timothy M. Greco, MD, FACS, a double-board-certified facial plastic and reconstructive surgeon with close to 30 years of experience in the ...

The research illustrated “substantial benefits” of enhanced optometry services in community practices handling conditions ...